Through the expansion of the nuclear medical facilities, Taipei Medical University has enabled the application of image interpretation studies in basic and clinical research
Published on 2020-08-03
In Dec 2019, Taipei Medical University completed the establishment of the positron emission tomography (PET) facilities.
The technology, through the future enabling of clinical in vivo images being constructed through animal PET image analyses with radiotracers and the accelerating of new drug development and screening, will be an essential bridge between basic and clinical research for image interpretation studies.
Did you know?
|Nuclear medicine is a non-invasive medical technology. Positron emission tomography (PET) is carried out through the imaging of the distribution of radioactive tracers in the body and can be employed in early clinical diagnosing and curative effect tracking; individualized therapeutic strategies can be prepared for different patients, raising the medical success rates and effectively reducing mortality rates, hence providing a valuable tool in individualized and precise medicine.|
Concerning high level medical imaging, Taipei Medical University plans to play the central role in the linking of pre-clinical molecular imaging medical researching techniques and clinical medical research, further promoting the technology and environment with core essential techniques and potential target development.
As for medical technology, in order to keep up with the new international trends of the biomedical industry and individualized chemotherapy, the developing of precise medicine will be focused on; molecular medicine core techniques will be promoted integrating our capability in basic medical research and clinical trial experiences. In the future, to achieve precise medical technology, optimized preventive, diagnostic, and therapeutic systems will be established concentrating on cancer and degenerative neural diseases.